Primary biliary cirrhosis: A multi-faced interactive disease involving genetics, environment and the immune response

Raivo Uibo, Kai Kisand, Chen Yen Yang, M. Eric Gershwin

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Primary biliary cirrhosis (PBC) is considered a model autoimmune disease based on several features, including the presence of a highly directed and very specific immune response to mitochondrial autoantigens, a female predominance, a targeted destruction of the biliary epithelium, and homogeneity between patients. It is essentially a chronic progressive cholestatic liver disease characterized by immune-mediated destruction of small- and medium-sized intrahepatic bile ducts. There is considerable variation in the incidence and prevalence of the disease between regions of the world, although such differences likely reflect not only a true disparity in disease but also differences in awareness; for example, in the United States, PBC is often detected in an asymptomatic stage based on multi-phasic clinical testing. There has been considerable progress at defining the immune response in this disease, including quantitation of autoreactive T cells against PDC-E2, the major mitochondrial autoantigen. The overwhelming data suggests that patients develop PBC based on a genetic predisposition and loss of tolerance to one or more environmental agents. In this review, we will present an updated overview of PBC and place it in the context of autoimmunity.

Original languageEnglish (US)
Pages (from-to)857-871
Number of pages15
JournalAPMIS
Volume120
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

Inborn Genetic Diseases
Biliary Liver Cirrhosis
Intrahepatic Bile Ducts
Autoantigens
Genetic Predisposition to Disease
Autoimmunity
Autoimmune Diseases
Liver Diseases
Epithelium
T-Lymphocytes
Incidence

Keywords

  • Antibodies
  • Autoantigens
  • Etiology
  • Genes
  • Innate immunity
  • Microorganisms
  • Primary biliary cirrhosis
  • Xenobiotics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Microbiology (medical)
  • Immunology and Allergy

Cite this

Primary biliary cirrhosis : A multi-faced interactive disease involving genetics, environment and the immune response. / Uibo, Raivo; Kisand, Kai; Yang, Chen Yen; Gershwin, M. Eric.

In: APMIS, Vol. 120, No. 11, 11.2012, p. 857-871.

Research output: Contribution to journalArticle

@article{a7a1348e2e3541e1abfafbe53d0e9966,
title = "Primary biliary cirrhosis: A multi-faced interactive disease involving genetics, environment and the immune response",
abstract = "Primary biliary cirrhosis (PBC) is considered a model autoimmune disease based on several features, including the presence of a highly directed and very specific immune response to mitochondrial autoantigens, a female predominance, a targeted destruction of the biliary epithelium, and homogeneity between patients. It is essentially a chronic progressive cholestatic liver disease characterized by immune-mediated destruction of small- and medium-sized intrahepatic bile ducts. There is considerable variation in the incidence and prevalence of the disease between regions of the world, although such differences likely reflect not only a true disparity in disease but also differences in awareness; for example, in the United States, PBC is often detected in an asymptomatic stage based on multi-phasic clinical testing. There has been considerable progress at defining the immune response in this disease, including quantitation of autoreactive T cells against PDC-E2, the major mitochondrial autoantigen. The overwhelming data suggests that patients develop PBC based on a genetic predisposition and loss of tolerance to one or more environmental agents. In this review, we will present an updated overview of PBC and place it in the context of autoimmunity.",
keywords = "Antibodies, Autoantigens, Etiology, Genes, Innate immunity, Microorganisms, Primary biliary cirrhosis, Xenobiotics",
author = "Raivo Uibo and Kai Kisand and Yang, {Chen Yen} and Gershwin, {M. Eric}",
year = "2012",
month = "11",
doi = "10.1111/j.1600-0463.2012.02914.x",
language = "English (US)",
volume = "120",
pages = "857--871",
journal = "Acta Pathologica Microbiologica et Immunologica Scandinavica - Section B Microbiology",
issn = "0365-5555",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Primary biliary cirrhosis

T2 - A multi-faced interactive disease involving genetics, environment and the immune response

AU - Uibo, Raivo

AU - Kisand, Kai

AU - Yang, Chen Yen

AU - Gershwin, M. Eric

PY - 2012/11

Y1 - 2012/11

N2 - Primary biliary cirrhosis (PBC) is considered a model autoimmune disease based on several features, including the presence of a highly directed and very specific immune response to mitochondrial autoantigens, a female predominance, a targeted destruction of the biliary epithelium, and homogeneity between patients. It is essentially a chronic progressive cholestatic liver disease characterized by immune-mediated destruction of small- and medium-sized intrahepatic bile ducts. There is considerable variation in the incidence and prevalence of the disease between regions of the world, although such differences likely reflect not only a true disparity in disease but also differences in awareness; for example, in the United States, PBC is often detected in an asymptomatic stage based on multi-phasic clinical testing. There has been considerable progress at defining the immune response in this disease, including quantitation of autoreactive T cells against PDC-E2, the major mitochondrial autoantigen. The overwhelming data suggests that patients develop PBC based on a genetic predisposition and loss of tolerance to one or more environmental agents. In this review, we will present an updated overview of PBC and place it in the context of autoimmunity.

AB - Primary biliary cirrhosis (PBC) is considered a model autoimmune disease based on several features, including the presence of a highly directed and very specific immune response to mitochondrial autoantigens, a female predominance, a targeted destruction of the biliary epithelium, and homogeneity between patients. It is essentially a chronic progressive cholestatic liver disease characterized by immune-mediated destruction of small- and medium-sized intrahepatic bile ducts. There is considerable variation in the incidence and prevalence of the disease between regions of the world, although such differences likely reflect not only a true disparity in disease but also differences in awareness; for example, in the United States, PBC is often detected in an asymptomatic stage based on multi-phasic clinical testing. There has been considerable progress at defining the immune response in this disease, including quantitation of autoreactive T cells against PDC-E2, the major mitochondrial autoantigen. The overwhelming data suggests that patients develop PBC based on a genetic predisposition and loss of tolerance to one or more environmental agents. In this review, we will present an updated overview of PBC and place it in the context of autoimmunity.

KW - Antibodies

KW - Autoantigens

KW - Etiology

KW - Genes

KW - Innate immunity

KW - Microorganisms

KW - Primary biliary cirrhosis

KW - Xenobiotics

UR - http://www.scopus.com/inward/record.url?scp=84866841718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866841718&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0463.2012.02914.x

DO - 10.1111/j.1600-0463.2012.02914.x

M3 - Article

C2 - 23009110

AN - SCOPUS:84866841718

VL - 120

SP - 857

EP - 871

JO - Acta Pathologica Microbiologica et Immunologica Scandinavica - Section B Microbiology

JF - Acta Pathologica Microbiologica et Immunologica Scandinavica - Section B Microbiology

SN - 0365-5555

IS - 11

ER -